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PSGL-1-Mediated Adhesion of Human
Hematopoietic Progenitors to P-Selectin
Results in Suppression of Hematopoiesis
(CAMs) that are responsible for mediating interactions
between HPC and BM stromal cells in vitro. These stud-
ies have shown that a wide variety of CAMs represent-
ing several adhesion molecule superfamilies, including
CD44 and various members of the integrin and immuno-
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One aspect of the biology of primitive HPC that is stillAustralia
poorly understood concerns the mechanisms responsi-²The Baker Medical Research Institute
ble for their homing to the BM. Studies of the mechanismLaboratory of Vascular Biology
of entry of mature leukocytes into tissues during inflam-Prahan, VIC 3181
mation have shown that this is a multistep process con-Australia
trolled by a dynamic interaction between CAMs ex-³Department of Microbiology-Immunology
pressed by both leukocytes and endothelial cells. TheNorthwestern Medical School
initial attachment and rolling of leukocytes is mediatedChicago, Illinois 60601
by the selectin family of CAMs (Kansas, 1996). This is
a family of three structurally related integral membrane
glycoproteins that participate in leukocyte adhesion toSummary
endothelium by means of selective cation-dependent
protein±carbohydrate interactions mediated by the lec-Cellular interactions are critical for the regulation of
tin-like domain at the N terminus of each selectin (Lasky,hematopoiesis. The sialomucin PSGL-1/CD162 medi-
1992). Leukocyte (L)-selectin (CD62L) is constitutivelyates the attachment of mature leukocytes to P-selec-
expressed by the majority of circulating leukocytes (Ted-tin. We now show that PSGL-1 also functions as the
der et al., 1990); endothelial (E)-selectin (CD62E), bysole receptor for P-selectin on primitive human CD341
endothelial cells following treatment by inflammatory me-hematopoietic progenitor cells (HPC). More impor-
diators (Bevilacqua et al., 1989); and platelet (P)-selectintantly, ligation of PSGL-1 by immobilized or soluble
(CD62P), by activated platelets and endothelial cellsligand or anti-PSGL-1 antibody results in a profound
(Kansas, 1996). A recent report from Frenette et al. sug-suppression of HPC proliferation stimulated by potent
gests that both P- and E-selectins are also essential forcombinations of early acting hematopoietic growth
the homing of HPC to the BM (Frenette et al., 1998).factors. These data demonstrate an unanticipated but
Previous studies from this laboratory have shown thatextremely marked growth-inhibitory effect of P-selec-
P-selectin supports the shear resistant adhesion of bothtin on hematopoiesis and provide direct evidence that
myeloid and erythroid progenitor cells in addition to theirPSGL-1, in addition to its well-documented role as an
hierarchically more primitive precursors (pre-CFU) andadhesion molecule on mature leukocytes, is a potent
implicated PSGL-1/CD162 in this process (Zannettinonegative regulator of human hematopoietic progen-
et al., 1995).itors.
We now show that PSGL-1 appears to be the sole
receptor for P-selectin on human HPC. In addition, we
Introduction demonstrate that adhesion to P-selectin results in a
profound inhibition of the growth and development of
Adhesive interactions are critical to the regulation of HPC when assayed under cytokine-dependent, stromal
hematopoiesis (Dexter, 1982; Simmons et al., 1997; Ver- cell±free culture conditions. Adhesion to P-selectin ap-
faillie, 1998). Under steady state conditions, the majority pears to preferentially inhibit the growth of primitive
of primitive hematopoietic stem cells (HSC) and their CD341CD382 HPC. This inhibition could not be over-
immediate progeny are restricted to the bone marrow come by combinations of hematopoietic growth factors
(BM), where they exist in physical association with a known to maximally recruit and expand primitive HPC.
heterogeneous collection of nonhematopoietic cells that These data therefore provide evidence of the signaling
comprise the stromal tissue of the BM. The localization function of PSGL-1 on primitive human HPC and suggest
of hematopoiesis to the BM involves developmentally the existence of a novel and potentially physiologically
regulated adhesive interactions between primitive he- relevant mechanism responsible for the negative regula-
matopoietic cells (HPC) and the stromal cell±mediated tion of primitive hematopoietic cells.
hematopoietic microenvironment (Wolf, 1979; Dexter,
1982; Verfaillie et al., 1990). Accordingly, much effort has Results
been devoted to identifying the cell adhesion molecules
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Figure 1. Primitive Bone Marrow Hematopoietic Progenitor Cells
Express PSGL-1 Protein
Figure 2. The Function-Blocking Anti-PSGL-1 mAb KPL1 and the
Bone marrow mononuclear cells were labeled with mAbs CD34,
Protease Mocarhagin Block CD341 Cell Adhesion to P-Selectin but
CD38, or CD19 and the anti-PSGL-1 mAb KPL1. In (A), CD34 expres-
Not to E-Selectin
sion (Cy5PE channel) was analyzed versus KPL1 binding (FITC chan-
(A) Calcein-AM-labeled BM CD341 cells were assayed for their abil-nel). In (B and C), analyses were gated on CD341 cells to measure
ity to attach to P-selectin purified from human platelets. Prior toexpression of PSGL-1 (FITC channel) versus CD38 and C19 (PE
deposition in coated wells, cells were incubated for 20 min at 48Cchannel) within the CD341 population.
in the presence of indicated concentrations of the anti-PSGL-1 mAb
KPL1 (black circles) or the isotypic control 1B5 (white circles). Re-
sults are expressed as a percentage of cell input and represent the
anti-human PSGL-1 antibodies KPL1 (Snapp et al., 1998), mean 6 SD of a typical experiment made in triplicate among three
independent experiments.PL1, and PL2 (Li et al., 1996) binding to three distinct
(B) 51Cr-labeled BM CD341 cells were assayed for their ability toepitopes of the PSGL-1 molecule. These three anti-
bind to CHO cells stably expressing either human P-selectin (blackPSGL-1 mAbs bound to approximately 80% of CD341
bars) or E-selectin (gray bars) and to control CHO cells (white bars).
cells, which included essentially all cells exhibiting high Prior to adhesion, CD341 cells were treated with either the function-
levels of CD34 antigen (CD34bright) (Figure 1A). When the blocking a-CD62E mAb 5B11, an isotypic control, or mocarhagin.
analysis was gated on CD341 cells, PSGL-1 was further Data represent the mean 6 SEM of three independent experiments.
shown to be expressed by 95% of primitive HPC, as
demonstrated by their low-to-absent levels of CD38
(CD341CD38lo/2) (Figure 1B) and by the immediate prog- (Romo et al., 1999). Similar analyses were therefore per-
formed using two anti-human GPIba mAbs, AK2 andeny of these cells, the CD341CD381 subpopulation
shown in many previous reports to contain the majority WM23, but neither antibody demonstrated detectable
binding to CD341 HPC (data not shown). These dataof lineage-restricted clonogenic HPC (Terstappen et al.,
1991). Flow cytometric analyses performed with two other regarding the pattern of expression of PSGL-1 on CD341
cells therefore appear completely consistent with ouranti-PSGL-1 mAbs, PL1 and PL2, gave identical results
(data not shown). A subpopulation of CD341CD38bright previous functional analysis of the adhesion of CD341
cells to P-selectin (Zannettino et al., 1995).cells characterized by low CD34 antigen density failed
to bind anti-PSGL-1 mAbs. These CD34dimPSGL-12 cells We next performed adhesion assays using CD341 BM
cells in order to investigate the contribution of PSGL-1were shown to express the B cell±specific cell surface
antigen CD19 (Figure 1C), a subpopulation of CD341 to the adhesion of these cells to purified human platelet
P-selectin. Experiments shown in Figure 2A were per-cells that in our previous report were found not to bind
P-selectin (Zannettino et al., 1995). formed in the presence of KPL1, a function-blocking
anti-human PSGL-1 mAb that binds to the N-terminalThe platelet glycoprotein GPIba has been reported as
an additional tyrosine-sulfated receptor for P-selectin sulfated tyrosine residues essential for PSGL-1 activity
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(Snapp et al., 1998). Following incubation on P-selectin-
coated wells, 73% of CD341 cells remained attached to
P-selectin, a proportion in good accord with previous
flow cytometry analyses. Pretreatment of CD341 cells
with KPL1 induced a dose-dependent inhibition of cell
adhesion to P-selectin, whereas the isotype-matched
IgG1 control had no effect. This inhibition was complete
at KPL1 concentrations in excess of 1 mg/ml. To further
document that PSGL-1 is the sole receptor for P-selectin
present on BM CD341 cells, we next performed adhe-
sion assays using CHO cells stably transfected with
either human P- or E-selectin. The cobra venom metallo-
proteinase mocarhagin cleaves a 10 amino acid peptide
from the N terminus of the mature PSGL-1 glycoprotein,
thereby preventing PSGL-1-mediated adhesion of neu-
trophils to P-selectin (Deluca et al., 1995). Treatment of
CD341 cells with mocarhagin resulted in the complete
abolition of their adhesion to P-selectin but had no effect
on their binding to E-selectin (Figure 2B). The specific
cleavage of the N-terminal peptide from PSGL-1 by mo-
carhagin (Deluca et al., 1995) was assessed by flow
cytometric analysis of enzyme or mock-treated CD341
cells. The binding of KPL1, which recognizes the three
Figure 3. Adhesion to Immobilized P-Selectin Inhibits Hematopoie-
tyrosine-sulfated residues in positions 5, 7, and 10 of sis in a Stroma-Free, Cytokine-Dependent Culture System
human PSGL-1 (Snapp et al., 1998), was abolished by CD341 cells (103) were plated over immobilized CD62P-IgG1Fc
treatment with mocarhagin, whereas the binding of PL1 (squares) or CD4-IgG1Fc (circles) fusion proteins and were cultured
and PL2, recognizing epitopes further downstream (Li in SDM supplemented with 36GS. At days 7, 14, 21, and 28 of liquid
cultures, an aliquot was taken from each well to assess nucleatedet al., 1996), remained unaltered (data not shown). Col-
cell (A) and clonogenic cell numbers (B) as described in Experimentallectively, these data demonstrate that the sole receptor
Procedures (pre-CFU assay). These data represent the mean 6 SEMfor P-selectin expressed by CD341 HPC is PSGL-1.
of three independent experiments.
Adhesion to P-Selectin Suppresses Hematopoiesis
in Stroma-Free, Cytokine-Dependent Culture
soluble KPL1 inhibited CD341CD382 cell growth in aExperiments were performed to investigate the potential
dose-dependent manner even in the absence of immobi-functional significance of PSGL-1-mediated adhesion
lized P-selectin, whereas the isotypic control 1B5 hadof HPC to P-selectin. CD341 cells purified from normal
no such effect (Figure 4). Thus, ligation of PSGL-1 eitherBM were allowed to bind to a recombinant form of
by its physiological ligand P-selectin or the specific mAbhuman P-selectin comprising its extracellular domain
KPL1 inhibits the growth of primitive HPC.fused to the Fc region of human IgG1 (CD62P-Fc). Con-
trol wells were coated with a human CD4-Fc construct.
Growth of the bound CD341 cells was stimulated by
the addition of a combination of four cytokines (36GS)
consisting of IL-3, IL-6, G-CSF, and kit ligand/stem cell
factor (SCF), which in previous studies has been shown
to provide an efficient stimulus for the growth of CD341
cells in stroma-free suspension culture (Makino et al.,
1997).
As shown in Figure 3, culture of CD341 cells on
CD62P-Fc-coated wells resulted in a profound inhibition
of hematopoiesis relative to that occurring in control
wells. Production of myeloid cells progressively de-
clined throughout the course of the assay, culminating in
an approximate 90% decrease in overall cell production
compared to controls by day 28 of culture. De novo
CFU-GM generation was similarly affected, resulting in
undetectable levels of clonogenic progenitors at the
Figure 4. KPL1 Inhibits the Growth of CD341CD382 Cells in a Dose-time of culture termination on day 28. Similar inhibition
Dependent Mannerwas observed in subsequent cultures established on
CD341CD382 cells were plated at a concentration of 2 3 104 cells/wells coated with purified native human P-selectin (data
ml in SDM supplemented with 36GS in the presence of indicatednot shown).
concentrations of the anti-PSGL-1 mAb KPL1 (black circles) or the
To assess the specificity of this effect, cultures of isotypic control 1B5 (white circles). Cell concentrations were deter-
CD341CD382 cells were established in the presence of mined after 6 days of culture. These data represent the mean 6
SEM of two independent experiments.the blocking anti-PSGL-1 mAb KPL1. We found that
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PSGL-1-Mediated Adhesion to P-Selectin Results
in the Induction of Apoptosis in a Subpopulation
of CD341CD382 Cells
To study the mechanism responsible for the inhibition
of hematopoiesis resulting from adhesion of HPC to
P-selectin, we first investigated whether the effect of
P-selectin was related to the stage of HPC differentia-
tion. Accordingly, a series of experiments were con-
ducted using CD341 cells fractionated by FACS into
CD341/CD382 and CD341/CD38bright subpopulations,
which were then plated in 96-well plates coated with
either human P-selectin purified from platelets or BSA.
After 7 days, the incidence of apoptotic cells in each
subpopulation was measured by means of a terminal
deoxynucleotidyl transferase±mediated dUTP nick end
labeling (TUNEL) assay. As shown in Figure 5A, adhesion
of the unfractioned CD341 population to purified P-se-
lectin resulted in the induction of apoptosis in 33.4% 6
15.0% compared to 8.6% 6 6.9% on BSA. In contrast,
only 3.8% 6 1.5% of CD341CD38bright cells underwent
apoptosis on P-selectin, a proportion not significantly
different from that observed on BSA. Most notably,
assay of the CD341CD382 subpopulation under these
conditions resulted in the induction of apoptotic cell
death in approximately 42.9% 6 3.1% of cells, a signifi-
cantly higher proportion than that observed either for
the same subpopulation cultured on BSA (p , 0.0001,
df 5 8) or for the CD341CD38bright population cultured
on purified P-selectin (p 5 0.0001, df 5 6).
Since KPL1, rather than inhibiting the effect of
P-selectin on the CD341CD382 subpopulation, acted as
an agonist (Figure 4), the specificity of this effect was
demonstrated by the partial but significant reversal of
the induction of apoptosis in assays performed in the
presence of a function-blocking rabbit anti-human
P-selectin antibody. P-selectin-coated wells were treated
Figure 5. Adhesion to Immobilized P-Selectin Induces Apoptosis offor 1 hr with either 20 mg/ml of anti-human P-selectin
a Subset of CD341CD382 Cells but Not CD341CD38bright Cells orimmunoglobulins or nonimmune rabbit immunoglobu-
Pre-CFUlins as a control. After extensive washing of the wells,
(A) CD341CD382 (gray bars), CD341CD38bright (white bars), and total5000 CD341CD382 cells were deposited and cultured
CD341 (black bars) cells were cultured for 7 days in SDM supple-for 7 days in the presence of 36GS. The proportion of
mented with 36GS on either immobilized P-selectin or BSA. The
apoptotic cells was reduced from 42% in P-selectin- percentage of apoptotic cells was determined by TUNEL. Data rep-
coated wells treated with nonimmune IgG to 29% in resents the mean 6 SEM of five independent experiments for
P-selectin-coated wells treated with anti-CD62P anti- CD341CD382 cells and three independent experiments for both
CD341CD38bright cells and total CD341 cells.bodies. Whereas the number of viable cells reached
(B) Sorted CD341CD382 HPC (1300) were plated in P-selectin (black16,200 6 100 after 7 days of culture in P-selectin-coated
circles) and BSA (white circles) coated wells. After 7 days of culturewells treated with anti-CD62P antibodies, it was reduced
in SDM supplemented with 36GS, cells were diluted 1/10 in freshto 5500 6 190 in P-selectin-coated wells treated with
SDM with 36GS and transferred into noncoated wells as indicated
nonimmune rabbit IgG. by the arrows. At days 14, 21, and 28 of the culture, cells were
In addition, we also examined the growth response counted and an aliquot was taken from each well to perform a
of single CD341CD382 cells deposited on either immobi- clonogenic assay (pre-CFU assay). After 14 days of secondary cul-
ture, the number of CFU-GM per 103 CD341CD382 input cells atlized P-selectin or BSA. As shown in Figure 6C, the
day 0 was determined (C). These data represent the mean 6 SEMgrowth inhibitory effects of P-selectin were also recapit-
of three independent experiments.ulated at the single-cell level, with CD341CD382 cells
exhibiting a significantly reduced incidence of recruit-
ment into division on P-selectin compared to BSA. Thus,
appeared not to undergo apoptosis following 7 day cul-the effects of P-selectin on the proliferation of primitive
ture on P-selectin. To examine the nature of these cells,HPC are direct and do not depend on cell±cell interac-
assays were again established using the CD341CD382tions.
subpopulation, and at day 7 cells were removed from
their respective substrata (P-selectin or BSA) and trans-Adhesion to P-Selectin Does Not Induce Apoptosis
ferred onto noncoated wells containing fresh growthof Primitive HPC
media and 36GS. As shown in Figure 5B, while thereAlthough inducing apoptosis in greater than 40% of
was a net increase in cell number from culture initiationCD341CD382 cells, the studies described above dem-
onstrated that a significant proportion of this population to day 7 in cultures established on BSA, over the same
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induction of apoptosis, nevertheless spared hierarchi-
cally more primitive pre-CFU (Haylock et al., 1992, 1997).
Adhesion to P-Selectin Reduces the Proliferation
Rate of CD341CD38bright Cells
Although attachment to immobilized P-selectin did not
induce apoptosis in more committed CD341CD38bright
cells, there was nevertheless a significant and reproduc-
ible 30% reduction of the output after 7 days of culture
in the presence of 36GS compared to cells grown on
immobilized BSA (p 5 0.017, df 5 2). When cells were
replated into plates freshly coated with P-selectin and
BSA and cultured for an extra period of 7 days with fresh
SDM and 36GS, the reduction of the output reached
approximately 50% for cells cultured on immobilized
P-selectin.
Flt-3 Ligand and Thrombopoietin Rescue CD341CD382
Cells from P-Selectin-Mediated Apoptosis
Subsequent experiments were performed to assess
whether hematopoietic growth factors acting on very
primitive HPC, such as Flt-3 ligand (FL) and thrombo-
poietin (TPO) (Haylock et al., 1997; Piacibello et al., 1997;
Luens et al., 1998), might prevent CD341CD382 cells from
undergoing apoptosis following attachment to P-selectin.
In these experiments, cultures of CD341CD382 cells
were established on wells coated with human P-selectin
purified from platelets or BSA in the presence of 36GS
or 36GS supplemented with 100 ng/ml FL ligand and
Figure 6. FL and TPO Rescue CD341CD382 Cells from Apoptosis TPO. After 7 days, the addition of either Flt-3 ligand or
but Do Not Override Growth Inhibition Mediated by Cell Adhesion TPO reduced the number of apoptotic cells from 47% 6
to P-Selectin 2% to 26% 6 1% and 28% 6 2%, respectively, whereas
CD341CD382 cells were plated into P-selectin (black bars) and BSA addition of both factors decreased the proportion of
(white bars) coated wells at 2 3 104 cells/ml in SDM supplemented
apoptotic cells down to 10.5% 6 6.1%, not significantlywith 36GS in the absence or presence of 100 ng/ml FL (F) and TPO
different from the proportion of apoptotic cells in BSA-(T). After 7 days of culture, cell concentrations (A) were measured.
These data represent the mean 6 SEM of three independent experi- coated wells (p 5 0.19, df 5 2). It was noteworthy, how-
ments. In (B) and (C), single-cell cultures of CD341CD382 cells were ever, that despite enhanced survival, cell growth was
established in Terasaki wells coated with P-selectin (black bars) or still decreased in P-selectin-coated wells compared to
BSA (white bars) and grown in SDM supplemented with 36GSFT (B)
BSA controls (Figure 6A). To further document this ef-or 36GS (C). The size of each clone was assessed on an inverted
fect, single-cell cultures of CD341CD382 cells were per-microscope at day 10 of the cultures. These data represent results
formed in Terasaki wells coated with platelet-derived P-of two Terasaki plates (120 wells) per each condition of coating and
growth factors. selectin or BSA, and the size and frequency of each
clone was monitored at various time points of the culture
(Figure 6B). In the presence of both FL and TPO, mostperiod the numbers of viable cells significantly declined
single CD341CD382 cells had divided after 10 days ofon P-selectin coated wells (p 5 0.014, df 5 5), in accord
culture in P-selectin-coated wells, showing increasedwith the previous studies demonstrating induction of
cell survival at a single-cell level. These cells, however,apoptosis under these conditions. However, following
gave rise to much smaller clones further, demonstratingtransfer to noncoated wells, both populations continued
that even following stimulation by a most potent combi-to support the de novo generation of HPC (CFU-GM)
nation of hematopoietic growth factors (Piacibello et al.,and their myeloid progeny over the subsequent 3 week
1997; Luens et al., 1998), P-selectin was still to able toperiod of the experiment. As shown in Figures 5B and
suppress hematopoiesis.5C, no significant differences in either CFU-GM genera-
tion (p 5 0.687, df 5 2) or total cell production (p 5
0.7938, df 5 2) were evident between the P-selectin or
Inhibitory Effects of Soluble P-SelectinBSA control groups at days 21 and 28 of culture, al-
In addition to its inducible expression on vascular endo-though in all experiments there was a trend toward both
thelial cells, P-selectin is also present as a soluble mole-reduced cell and CFU-GM production from the P-selec-
cule detectable in serum (Dunlop et al., 1992). Thistin group evident at day 14. Collectively, therefore, these
prompted us to examine whether the inhibition of hema-data demonstrate that adhesion of CD341CD382 cells
topoiesis observed as a consequence of adhesion toon surfaces coated with P-selectin, while resulting in
death of a proportion of this population through the immobilized platelet P-selectin also occurred with the
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myeloid progeny in the absence of marrow stromal cells
(Makino et al., 1997). The specificity of this effect was
demonstrated by the fact that (1) synthetic recombinant
CD62P-IgG1Fc fusion protein and natural P-selectin pu-
rified from platelets had the same effect, (2) ligation of
the PSGL-1 with the KPL1 mAb also resulted in inhibition
of hematopoiesis, and (3) pretreatment of immobilized
P-selectin with an anti-P-selectin polyclonal antibody
reversed this inhibition. Analysis of the effects of purified
platelet P-selectin on committed CD341 HPC (CD381)
and on their more immature precursors (CD382) dem-
onstrated distinct effects on these two populations.
Growth of CD341CD381 cells on P-selectin had no de-
monstrable effect on their viability but resulted in a sig-
nificantly reduced rate of proliferation relative to cellsFigure 7. Inhibitory Effect of Purified Soluble P-Selectin
grown on the control substratum. In contrast, 36GS-
CD341CD382 cells were cultured in SDM supplemented with 36GS
stimulated growth of CD341CD382 cells on P-selectinin the presence of indicated concentrations of soluble P-selectin
resulted in the induction of apoptosis in approximately(white circles) or BSA (black circles). P-selectin and BSA dilutions
40%±50% of cells after 7 days of culture. Thus, severalwere performed in P-selectin storage buffer in order to keep an
equivalent amount of storage buffer in each condition. Cell concen- distinct mechanisms acting in concert on hierarchically
trations were determined after 7 days of culture. These data repre- distinct populations of HPC appear to contribute to the
sent the mean 6 SD of a typical experiment made in triplicate among inhibition of hematopoiesis mediated by P-selectin. No-
three independent experiments.
tably, although binding to P-selectin resulted in the
death through apoptosis of a significant proportion of
CD341CD382 cells, primitive HPC within this phenotypesoluble molecule. As shown in Figure 7, addition of solu-
remained viable, as demonstrated by their capacity toble P-selectin also resulted in a dose-dependent inhibi-
initiate and sustain hematopoiesis in a pre-CFU assaytion of CD341 cell proliferation and induction of apopto-
once removed from contact with P-selectin. As the num-sis. In the presence of 3 mg/ml of soluble P-selectin,
ber of remaining viable cells did not increase duringapproximately 50% of CD341CD382 HPC were TUNEL-
the 7 day period of culture on immobilized P-selectin,positive after 7 days of culture.
this apoptosis-resistant subpopulation of CD341CD382
HPC remained quiescent in spite of the presence of the
Discussion
36GS cocktail. Finally, depending on the combination
of hematopoietic growth factors used to stimulate HPC,
In the current study, we demonstrate that human CD341
P-selectin-mediated apoptosis of CD341CD382 cells
BMMNC express PSGL-1 at their surface, in agreement
could be inhibited. Specifically, the addition of TPO and
with two recent reports (Laszik et al., 1996; Tracey and FL to 36GS was able to rescue these cells from apopto-
Rinder, 1996). In addition, analysis of PSGL-1 on defined sis but failed to override growth inhibition mediated by
subpopulations of CD341 HPC demonstrated high-level cell adhesion to P-selectin. Since both FL and TPO are
expression on both CD341CD382 and CD341CD381 important positive regulators of hematopoiesis (Mac-
cells, phenotypes highly enriched in candidate HSC and karhtschian et al., 1995; Carver-Moore et al., 1996), adhe-
in lineage-restricted clonogenic HPC, respectively (Ter- sion of primitive HPC to P-selectin might suppress hema-
stappen et al., 1991). Furthermore, CD341 cells coex- topoiesis without triggering apoptosis of CD341CD382
pressing CD19, which represent B-lymphoid precursors cells in vivo.
(Locken et al., 1987), exhibited low-to-undetectable lev- In regard to the potential physiological significance
els of PSGL-1 expression in accord with their lack of of these observations, several aspects should be con-
adhesion to P-selectin (Zannettino et al., 1995) and the sidered. First, recent data have demonstrated a function
lower level of PSGL-1 on mature B cells (Snapp et al., of P-selectin in megakaryopoiesis (Banu et al., 1995)
1998). The absence of expression of the other P-selectin and the essential role of both P- and E-selectin in the
receptor, the platelet glycoprotein GPIba (Romo et al., homing of HPC in the bone marrow following lethal irra-
1999), on CD341 cells, together with studies using either diation (Frenette et al., 1998). While the question of con-
the function-blocking anti-PSGL-1 mAb KPL1 or the pro- stitutive or inducible expression of P-selectin at the
tease mocarhagin that specifically cleaves PSGL-1 (De- surface of BM endothelial cells remains at present
luca et al., 1995), demonstrated the functional role of unresolved (Beckstead et al., 1986; Hattori et al., 1989),
PSGL-1 in the adhesion of CD341 cells to P-selectin. it is noteworthy, however, that the other vascular selec-
Importantly, these results also showed that this sialomu- tin, E-selectin, appears to be expressed constitutively
cin appears to be the sole ligand for P-selectin ex- on endothelial cells in hematopoietic tissues (Schweitzer
pressed by these cells. et al., 1996; Frenette et al., 1998), as is the integrin ligand
In addition to its role as an adhesion molecule on VCAM-1 (Jacobsen et al., 1996; Schweitzer et al., 1996),
both primitive and clonogenic HPC, PSGL-1-mediated raising the possibility that a similar situation may exist
binding of CD341 cells to P-selectin was found to for P-selectin. Second, immunohistological staining has
markedly suppress the growth and development of revealed the presence of P-selectin at the surface of
these cells in response to 36GS, a combination of cyto- maturing megakaryocytic precursors (Beckstead et al.,
kines shown in previous studies to provide a potent 1986; Banu et al., 1996), which are also an integral part
of the hematopoietic microenvironment. In addition, astimulus for the ex vivo generation of HPC and their
Inhibition of Hematopoiesis by P-Selectin
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soluble form of P-selectin has been detected in the et al., 1996). Finally, antibody-mediated ligation of
plasma of normal individuals at levels ranging from 150± CD164, a sialomucin recently identified in this laboratory,
300 ng/ml (Dunlop et al., 1992) and may also be present results in the decreased recruitment of CD341CD382 cells
in the extravascular compartment of the BM. The physio- into cycle (Zannettino et al., 1998). The transduction
logical source of soluble P-selectin has not been deter- pathways responsible for the inhibitory function of
mined but clearly may include either vascular endothelial PSGL-1 and sialomucins in hematopoietic cells are still
cells and/or megakaryocytes/platelets (Dunlop et al., unknown.
1992). In the present study, soluble P-selectin also re- In conclusion, these studies demonstrate that in addi-
sulted in a dose-dependent inhibition of hematopoiesis, tion to its well-documented role as a counter receptor
demonstrating that immobilization of the molecule is not for the vascular adhesion molecule P-selectin, the si-
required to mediate the growth inhibitory properties of alomucin PSGL-1 is a signaling molecule on primitive
P-selectin. HPC, and the transduced signals result in the inhibition
Finally, several authors have reported that mice defi- of hematopoiesis. Further work is now required to de-
cient in both P- and E-selectins and mice deficient in termine the molecular mechanisms responsible for
the a(1,3)fucosyltransferase T-VII, which is essential for P-selectin/PSGL-1-mediated growth inhibition in HPC.
the biosynthesis of functional selectin counterreceptors, In this respect, it will be of interest to determine to
exhibit a severe leukocytosis and enhanced hematopoi- what extent PSGL-1-mediated signaling overlaps with
esis in the BM and spleen (Frenette et al., 1996; Maly signaling generated by other sialomucins and induced
et al., 1996). These authors hypothesized that this en- by suppressive cytokines such as transforming growth
hancement of hematopoiesis was the result of an in- factor-b (Hatzfeld et al., 1991) and macrophage inflam-
creased production of cytokines by immune cells whose matory protein-1a related chemokines (Broxmeyer et
behavior following infection was altered by selectin or al., 1993).
fucosyltransferase deficiency. However, given the pres-
ent findings, the elevated neutrophil counts and altered Experimental Procedures
hematopoiesis observed in these animals may result
BMMNC and Isolation of CD341 HPCfrom disruption of inhibition of hematopoiesis normally
Normal BM from the sternum and posterior iliac crest of healthymediated by the P-selectin/PSGL-1 interaction. The fact
young volunteers (following informed consent) was aspirated intothat this phenotype requires disruption of both P- and
preservative-free, sodium heparin±containing tubes. Low-density
E-selectin genes might be the result of overlapping sig- bone marrow mononuclear cells (BMMNC) were collected after cen-
naling mediated by PSGL-1 and E-selectin binding pro- trifugation at 400 3 g over Ficoll-Hypaque (d 5 1.077 g/ml). After
teins in HPC. Although the possibility that E-selectin three washes by centrifugation at 48C in HHF buffer (Hank's bal-
anced salt solution supplemented with 20 mM HEPES [pH 7.35] andmay bind to a further downstream region of PSGL-1
5% fetal calf serum [FCS]), CD341 HPC were then isolated with anti-(Goetz et al., 1997) cannot be excluded, several reports
CD34-conjugated Dynabeads as previously described (Zannettinosuggest that E-selectin binds to distinct receptors on
et al., 1998). As assessed by staining with phycoerythrin (PE)-conju-
hematopoietic cells (Steegmaier et al., 1995; Jones et gated HPCA-2 (Becton Dickinson), this procedure yielded CD341
al., 1997; Snapp et al., 1997; ZoÈ llner and Vestweber, populations with purity greater than 95%.
1997). PSGL-1 and E-selectin receptors might transduce
Detection of PSGL-1 and GPIba by Three-Color Cytofluorometrylargely overlapping signaling in HPC, as suggested by
Ficoll-separated BMMC were incubated on ice for 10 min with HHFexperiments performed in neutrophils (Homeister et al.,
containing normal human serum to block Fc receptors. All proce-1998). In such a situation, disruption of only P-selectin-
dures were performed with ice-cold HHF. Cell aliquots (1,000,000)mediated signaling would therefore not prevent the gen-
were labeled for 45 min at 48C with 2 mg anti-CD34 mAb 43A1 (mouse
eration of the suppressive signaling by the remaining IgG3) and either anti-PSGL-1 mAbs (KPL1, PL1, PL2), anti-GPIba
E-selectin receptors, implying the requirement of the mAbs (AK2, WM23), or their mouse IgG1 isotypic control (1B5). After
disruption of signaling generated by both selectins to washing cells twice, BMMNC were incubated for 45 min at 48C with
FITC-conjugated goat anti-mouse IgG1 and biotinylated goat anti-observe this phenotype.
mouse IgG3 (Caltag). After washing cells twice, unbound sites ofA series of recent reports suggest that mucin-like mol-
FITC-conjugated goat anti-mouse IgG1 were blocked by a 45 minecules such as PSGL-1, CD164, leukosialin (CD43), and
incubation with the control mouse IgG1 1B5. After two washes,CD34 belong to an emerging family of cell adhesion BMMNC were finally incubated with Cy5PE-conjugated streptavidin
receptors called sialomucins, which transduce negative (Southern Biotechnology) and PE-conjugated Leu-17, anti-CD19, or
signals in hematopoietic cells. For instance, constitutive control IgG1 (Becton Dinckinson). After three washes, cells were
fixed in 1% paraformaldehyde. Flow cytometric analysis was per-expression of the full-length splice variant of CD34 in
formed using a Profile II flow cytometer (Coulter). Events (500,000)murine M1 cells has been shown to inhibit cytokine-
were collected per sample as list mode data and analyzed usinginduced differentiation (Fackler et al., 1995). Consistent
Coulter ELITE software. The specificity and blocking of secondarywith this result, CD34-deficient mice exhibit decreased
antibodies and compensation settings were assessed by analyzing
numbers of HPC in the bone marrow and spleen as a cells labeled with all the possible combinations of reactive and
possible result of augmented differentiation (Cheng et nonreactive unconjugated mouse IgG1 and IgG3 and reactive and
al., 1996). Similar to the effects mediated by P-selectin nonreactive PE-conjugated mouse IgG1.
and PSGL-1, antibody-mediated cross-linking of CD43
P-Selectin and Well Coatingresults in the induction of apoptosis in human CD341
These studies were performed using several forms of P-selectinHPC. Multipotential progenitors (CFU-GEMM) and ery-
including native P-selectin purified from human platelets, recombi-throid progenitors (BFU-E) were substantially more sen-
nant P-selectin-IgG1 Fc fusion protein, and Chinese hamster ovarysitive to CD43-induced apoptosis than myeloid progeni- (CHO) cells transfected with a human P-selectin cDNA. P-selectin
tors (CFU-GM). Although expressing CD43 at high level, purified from human platelets was prepared as previously described
candidate HSC were apparently refractory to the apo- (Skinner et al., 1991) and stored at 2708C in 0.02 M Tris buffer (pH
7.4), 0.15 M NaCl, 0.1% Triton X-100, and 1 mM CaCl2 (storageptosis-inducing effects of the anti-CD43 antibody (Bazil
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buffer). Wells were coated for 4 to 16 hr at 48C with 20 mg/ml purified 35 mm Petri dishes in the presence of IL-3, IL-6, GM-CSF, G-CSF,
and SCF as previously described (Haylock et al., 1997; Makino etP-selectin in storage buffer. Wells coated with BSA diluted in storage
buffer served as control. Unbound P-selectin was then removed al., 1997), and the number of colonies was recorded after 14 days
of culture.and the wells were blocked for 1 hr at room temperature with Iscove
modified Dulbecco's medium (IMDM) supplemented with 1% BSA
and washed five times with assay buffer prior to the assay.
Sorting and Single-Cell Deposition and CultureAlternatively, cell cultures were also performed with purified re-
Terasaki plates (60 well) were coated at 48C for 4 hr with 1 ml ofcombinant CD62P-IgG1Fc fusion protein (Figure 3). A CD4-IgG1Fc
either P-selectin or BSA at 20 mg/ml in P-selectin storage buffer.chimera prepared in an identical manner was employed as a control.
After five washes with PBS containing 1% BSA, wells were filledTo immobilize the CD62-Fc and CD4-Fc constructs, wells were first
with 10 ml of SDM supplemented with 36GS. Single CD341CD382coated overnight at 48C with 20 mg/ml of a monoclonal mouse anti-
cells were then sorted directly into each Terasaki well using thehuman IgG1Fc antibody diluted in phosphate-buffered saline (PBS).
automated cell deposition unit of the FACStarPlus (Becton Dickinson)After washing with PBS, wells were blocked for 2 hr at 378C with
as follows. CD341 HPC purified with 561-Dynabeads were resus-PBS containing 1% BSA and then incubated with the fusion proteins
pended in blocking buffer and incubated for 30 min at 48C. Cellsdiluted to 20 mg/ml in PBS for 2 hr at 408C. Before commencing the
were pelleted and labeled with HPCA-2-PE and Leu-17-FITC mAbsassay, the wells were washed five times with assay buffer.
or isotype-matched control for 1 hr at 48C. Cells were washed thriceCHO cells transfected with a human P-or E-selectin cDNA have
in sterile HHF. Subpopulations were then selectively isolated withbeen described previously (Zannettino et al., 1995) and were main-
a FACStarPLUS. Sorted cells (50,000±100,000) were collected directlytained in Ham's F12 medium supplemented with 10% FCS and 300
into IMDM 10% FCS. Alternatively, single sorted CD341CD382 cells
mg/ml G418. For use in adhesion assays, P-selectin, E-selectin, and
were deposited in Terasaki plates precoated with purified P-selectincontrol untransfected CHO cells were plated in 96-well plates at
or BSA and filled with 10 ml SDM supplemented with 36GS with or3 3 104 cells/well 24 hr prior to the assay.
without FL and TPO each at 100 ng/ml. Terasaki plates were then
centrifuged (200 3 g, 5 min) to sediment cells and examined within
Adhesion Assays 24 hr using an inverted phase microscope to determine the propor-
Adhesion assays of CD341 cells to P- and E-selectin transfected tion receiving only a single cell. Plates were cultured at 378C, and
CHO cells were performed as previously described (Zannettino et at days 3, 5, 7, and 10, the percentage of dividing cells was recorded
al., 1995). In order to demonstrate specificity of adhesion, assays in each well using an inverted microscope.
were performed following the incubation of transfected CHO cells
with function-blocking mAb 5B11 directed against human E-selectin
Assessment of Apoptosis by TUNEL Assayor an isotype-matched, nonbinding control mAb. To examine the
The proportion of apoptotic cells was determined after specificeffect of pretreatment of CD341 cells with mocarhagin on P-selectin
staining with the In Situ Cell Death Detection Kit AP (#1684809) frombinding, cells were washed in RPMI 1640 medium supplemented
Boehringer Mannheim. Briefly, after 7 days of culture in microwellswith 1% FCS. Cells were then treated with 10 mg/ml mocarhagin or
precoated with P-selectin or BSA, cells were harvested and cyto-an equivalent volume of PBS in mock-treated samples for 30 min at
spun onto glass slides for 5 min at 400 rpm and immediately air228C. Cells were centrifuged and washed twice with RPMI 1640±1%
dried for 1 hr at room temperature. Cells were fixed, stained, andFCS. Their adhesion to transfected CHO cells and the binding of
permeabilized following instructions provided with the kit. TUNEL-KPL1, PL1, and PL2 mAbs were assessed as described above.
positive apoptotic cells were revealed following a 5 min incubationAdhesion assays with purified platelet-derived P-selectin were
of slides with a 330 mg/ml nitro blue tetrazolium and 165 mg/mlperformed using calcein-AM-labeled CD341 cells. Briefly, CD341
5-bromo-4-chloro-3-indolyl phosphate in 0.1 M Tris-HCl (pH 9.5),cells were washed twice and resuspended in 500 ml IMDM 0.2%
0.1M NaCl, and 5 mM MgCl2. The staining reaction was stopped byBSA. Cells were labeled with 10 mM calcein-AM (Molecular Probes)
rinsing slides with water. Apoptotic cells had their nuclei stainedat 378C for 40 min, then washed thrice with IMDM 0.2% BSA and
blue, while viable cells remained unstained.diluted to a final concentration of 1±2 3 105 cells/ml. Aliquots (100
ml) of labeled cells were added to each coated well and plates were
rotated for 5 min at 1000 rpm at 48C to sediment cells into direct,
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